Cuba studied a total of 50,925 samples to detect COVID 19, resulting in 7,695 tests. The country accumulates 9, 271,041 samples taken and 839,981 positive.

The Center for State Control of Medicines, Equipment and Medical Devices (CECMED by its Spanish acronym) approved the authorization for emergency use of the Cuban vaccine Soberana Plus, developed by the Finlay Institute of Vaccines.

Cuba wakes up today with a total of 5,513 patients in pediatric ages hospitalized with COVID-19, of which 1,550 were diagnosed in the last day.

Cuban President Miguel Díaz-Canel thanked today on Twitter all those who made it possible for the country to have the required number of anti-COVID-19 doses to immunize the entire population.

People in the city of Las Tunas who are allergic to Thiomersal began to receive the first dose of the Chinese anti-COVID-19 vaccine Sinopharm in 35 vaccination stations.

Representatives of the University of Havana (UH) and the Cuban Academy of Language (ACuL) will sign today in this city a framework agreement to contract providers of goods, works and services widely used in state public administrations.

France will grant a 45-million-Euro fund to Cuba which will allow the local Finlay Vaccine Institute to expand the production of vaccines against meningitis and pneumonia.

The office of the Ministry of Science, Technology and the Environment (CITMA) in the province of Santiago de Cuba delivered medical supplies donated by the population to a children’s hospital in the provincial capital, in solidarity with those infected with COVID-19.

Cuba reported today 7,151 new COVID-19 cases, 59 deaths, and 7,759 medical discharges.

Since the province of Pinar del Río is today the epicenter of COVID-19 in Cuba, Public Health Minister José Ángel Portal Miranda urged to strengthen community work, step up the vaccination process and ensure service quality to make a change.

Volunteers included in the Soberana Centro clinical trial in the municipality of Palmira, in the province of Cienfuegos, were grateful for the opportunity to be part of a process of such magnitude, designed to evaluate the vaccine Soberana 01’s immune response against that of Soberana 02 and Soberana Plus as a booster.

At the end of September 19, 18, 402,491 doses of the Cuban anti-COVID-19 Soberana 02, Soberana Plus and Abdala vaccines had been administered in Cuba.

Cuba studied a total of 51,261 samples for detecting COVID 19, resulting in 8,289 positive tests. The country accumulates 9, 112,128,128 samples taken and 818,200 positive.

Vaccination against COVID-19 for those allergic to thiomersal will begin throughout the country this week, announced today Dr. Maria Elena Soto Entenza, head of the primary health care department (APS by its Spanish acronym) of the Ministry of Public Health of Cuba (MINSAP by its Spanish acronym).